Finance Home - My Yahoo - Yahoo! - Help

Thursday, December 10, 2009, 6:15AM ET - U.S. Markets open in 3 hours and 15 minutes. Dow  0.50% Nasdaq  0.00%

Eurand N.V. (EURX)

On Dec 9: 11.97   0.00 (0.00%)

MORE ON EURX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Dec 9, 2009 • Coverage initiated on Eurand by Caris & Company Briefing.com (Wed 9:25am) Mon, Nov 30, 2009 • Eurand Launches ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules Marketwire (Mon, Nov 30) Fri, Nov 13, 2009 • Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency Marketwire (Fri, Nov 13) Thu, Nov 5, 2009 • Eurand N.V. Q3 2009 Earnings Conference Call at Seeking Alpha (Thu, Nov 5) • Q3 2009 EURAND N V Earnings Release - 07:00 am ET CCBN (Thu, Nov 5) • Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009 Marketwire (Thu, Nov 5) Wed, Oct 28, 2009 • Eurand to Participate in Upcoming Investor Conferences Marketwire (Wed, Oct 28) • Eurand Completes Public Offering, Including Exercise of the Underwriters' Over-Allotment Option, for Total Net Proceeds of Approximately $103.9 Million Marketwire (Wed, Oct 28) Thu, Oct 22, 2009 • IPOs Looking Iffy at CNBC (Thu, Oct 22) • Eurand Announces Pricing of Offering of Ordinary Shares Marketwire (Thu, Oct 22) Tue, Oct 20, 2009 • Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst Wall Street Transcript (Tue, Oct 20) Thu, Oct 15, 2009 • Eurand, shareholders offering 8.5 million shares AP (Thu, Oct 15) • Eurand Announces Proposed Public Offering of Ordinary Shares Marketwire (Thu, Oct 15) Mon, Oct 5, 2009 • Eurand Announces Conference Call on Third Quarter 2009 Financial Results Marketwire (Mon, Oct 5) Mon, Sep 28, 2009 • Eurand files to sell 8.5 million shares AP (Mon, Sep 28) • Eurand Announces Filing of F-3 Registration Statement Marketwire (Mon, Sep 28) Wed, Sep 16, 2009 • Eurand to Present at UBS Global Life Sciences Conference Marketwire (Wed, Sep 16) Fri, Aug 28, 2009 • Today's 5-Star Movers at Motley Fool (Fri, Aug 28) • Eurand Granted FDA Approval for ZENPEP(TM) Marketwire (Fri, Aug 28) Wed, Aug 19, 2009 • Eurand to Participate in Upcoming Investor Conferences Marketwire (Wed, Aug 19) Older Headlines - Download Recent Headlines View headlines from: Wed, Aug 19, 2009Wed, Aug 12, 2009Wed, Aug 5, 2009Wed, Jul 29, 2009Wed, Jul 22, 2009Wed, Jul 15, 2009Wed, Jul 8, 2009Wed, Jul 1, 2009Wed, Jun 24, 2009Wed, Jun 17, 2009 Add EURX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage